Alzprotect

United States
Tonasket, Washington, United States, 59120

Company profile

Alzprotect company profile

AlzProtect is a biopharmaceutical company developing drug candidates from discovery to clinical trials for the treatment of neurodegenerative diseases including Alzheimer's disease (AD) and orphan tauopathies such as Progressive Supranuclear Palsy (PSP).

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0+
Founded
2007-01-01, Year

Headquarters

Postal code
59120
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
5
Total equity funding
$19.9M
Last funding
Grant / $338,000 / 2022-06-01
Last equity funding
Series B / $17.2M
Investors
6
Lead investors
3
Founders
1
Articles
9

Founders and investors

Founders

Philippe Verwaerde

Lead investors

FinorpaMichael J. Fox FoundationXerys

Investors

EurasanteFinorpaFinovam GestionMichael J. Fox FoundationXerys